Tag: lenvatinib
EMERALD-3 unlocks “secret key” to progression-free survival in locally advanced HCC
Single tremelimumab regular interval durvalumab (STRIDE) plus lenvatinib combined with transarterial chemoembolization (TACE)—a standard treatment for embolization-eligible hepatocellular carcinoma (HCC) that induces tumour immune...
